» Articles » PMID: 36156593

HIV Prevention for the Next Decade: Appropriate, Person-centred, Prioritised, Effective, Combination Prevention

Overview
Journal PLoS Med
Specialty General Medicine
Date 2022 Sep 26
PMID 36156593
Authors
Affiliations
Soon will be listed here.
Abstract

UNAIDS and a broad range of partners have collaborated to establish a new set of HIV prevention targets to be achieved by 2025 as an intermediate step towards the sustainable development target for 2030.The number of new HIV infections in the world continues to decline, in part due to the extraordinary expansion of effective HIV treatment. However, the decline is geographically heterogeneous, with some regions reporting a rise in incidence. The incidence target that was agreed for 2020 has been missed.A range of exciting new HIV prevention technologies have become available or are in the pipeline but will only have an impact if they are accessible and affordable and delivered within systems that take full account of the social and political context in which most infections occur. Most new infections occur in populations that are marginalised or discriminated against due to structural, legal, and cultural barriers.The new targets imply a new approach to HIV prevention that emphasises appropriate, person-centred, prioritised, effective, combination HIV prevention within a framework that reduces existing barriers to services and acknowledges heterogeneity, autonomy, and choice.These targets have consequences for people working in HIV programmes both for delivery and for monitoring and evaluation, for health planners setting local and national priorities, and for funders both domestic and global. Most importantly, they have consequences for people who are at risk of HIV exposure and infection.Achieving these targets will have a huge impact on the future of the HIV epidemic and put us back on track towards ending AIDS as a public health threat by 2030.

Citing Articles

AI applications in HIV research: advances and future directions.

Jin R, Zhang L Front Microbiol. 2025; 16:1541942.

PMID: 40051479 PMC: 11882587. DOI: 10.3389/fmicb.2025.1541942.


Oral pre-exposure prophylaxis implementation in South Africa: a case study of USAID-supported programs.

Milimu J, Parmley L, Matjeng M, Madibane M, Mabika M, Livington J Front Reprod Health. 2024; 6:1473354.

PMID: 39720121 PMC: 11666530. DOI: 10.3389/frph.2024.1473354.


Client experiences with "Dynamic Choice Prevention," a model for flexible patient-centred HIV prevention delivery in rural Eastern Africa.

Camlin C, Arunga T, Johnson-Peretz J, Akatukwasa C, Atwine F, Onyango A J Int AIDS Soc. 2024; 27(7):e26336.

PMID: 39020454 PMC: 11254577. DOI: 10.1002/jia2.26336.


Exploring linkages: addressing the relationship between the climate crisis and HIV prevention with recommendations for emerging pre-exposure prophylaxis programs.

Williams K, Olisa A, Wilcher R Front Reprod Health. 2024; 6:1369762.

PMID: 38596665 PMC: 11002151. DOI: 10.3389/frph.2024.1369762.


How PrEP delivery was integrated into public ART clinics in central Uganda: A qualitative analysis of implementation processes.

Wyatt M, Pisarski E, Nalumansi A, Kasiita V, Kamusiime B, Nalukwago G PLOS Glob Public Health. 2024; 4(3):e0002916.

PMID: 38452111 PMC: 10919847. DOI: 10.1371/journal.pgph.0002916.


References
1.
Young Holt B, Dellplain L, Creinin M, Peine K, Romano J, Hemmerling A . A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV. Eur J Contracept Reprod Health Care. 2018; 23(5):326-334. DOI: 10.1080/13625187.2018.1508650. View

2.
Godfrey-Faussett P . The HIV prevention cascade: more smoke than thunder?. Lancet HIV. 2016; 3(7):e286-8. DOI: 10.1016/S2352-3018(16)30062-5. View

3.
Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

4.
Ryan K, Asselin J, Fairley C, Armishaw J, Lal L, Nguyen L . Trends in Human Immunodeficiency Virus and Sexually Transmitted Infection Testing Among Gay, Bisexual, and Other Men Who Have Sex With Men After Rapid Scale-up of Preexposure Prophylaxis in Victoria, Australia. Sex Transm Dis. 2020; 47(8):516-524. PMC: 7357541. DOI: 10.1097/OLQ.0000000000001187. View

5.
Stelzle D, Godfrey-Faussett P, Jia C, Amiesimaka O, Mahy M, Castor D . Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis. PLoS Med. 2021; 18(1):e1003482. PMC: 7799816. DOI: 10.1371/journal.pmed.1003482. View